PEPG · PepGen Inc. · Metrics
$2.53
-0.07 (-2.69%)
At close · Oct 28
Return incl. dividend (before tax)
Q4 2023 earnings call transcript
Market Cap
$180.07M
Shares
69.26M
Volume · Oct 28
767.84K
Avg daily vol (3M)
934.42K
PEPG metrics
58 of 122 screener metrics currently available.
Market overview
2 metricsShare price
$2.53
Market cap
$180.07M
Price action
20 metricsPrice change (1W)
-9.4%
Price change (30D)
+0.4%
Price change (3M)
+42.1%
Price change (6M)
+64.6%
Price change (YTD)
-60.1%
Price change (1Y)
-52.1%
Trailing year
Price change (5Y)
—
52-week high
$7.17
52-week low
$1.35
Change from 52-week high
-63.7%
Change from 52-week low
+92.6%
Annualized volatility
107.7%
Annualized volatility (3M)
88.2%
Beta
0.0
RSI (14D)
49.8
Price vs SMA 50
-6.7%
Price vs SMA 200
-15.6%
Avg volume (3M)
932,191
Relative volume
1.4
Average dollar volume
$2.52M
Company
3 metricsSector
Healthcare
Industry
Biotechnology
Shares outstanding
69.26M
Valuation
12 metricsP / E (TTM)
—
Trailing earnings
PEG ratio
—
EV / revenue
—
EV / EBITDA
—
EV / EBIT
—
P / sales
—
P / book
1.4
reciprocal yield 69.3%
FCF yield
—
TTM · current market cap
Buyback yield
—
P / FCF
—
P / operating cash flow
—
Earnings yield
-41.7%
Historical valuation
8 metricsP / E historical average (3Y)
—
P / E historical average (5Y)
—
EV / revenue historical average (3Y)
—
EV / revenue historical average (5Y)
—
EV / EBIT historical average (3Y)
—
EV / EBIT historical average (5Y)
—
EV / EBITDA historical average (3Y)
—
EV / EBITDA historical average (5Y)
—
Dividends & buybacks
7 metricsDividend yield
—
Trailing 12 months
Payout ratio
—
Shareholder yield
—
Dividend / share (TTM)
—
Dividend growth YoY
—
Dividend growth streak
—
Last ex-dividend
—
Earnings calendar
2 metricsNext earnings
—
Last earnings
2026-03-30
Profitability
9 metricsGross margin
—
Operating margin
—
Trailing 12 months
Net margin
—
Gross profit (TTM)
—
Operating profit (TTM)
−$76.24M
Net income (TTM)
−$71.94M
Trailing 12 months
Diluted EPS (TTM)
$-1.02
FCF margin
—
Effective tax rate
—
Growth
11 metricsRevenue growth YoY
—
Year over year
Net income growth YoY
—
Revenue (TTM)
—
Trailing 12 months
EPS growth YoY
—
Shares change YoY
+111.3%
Year over year · more shares
Revenue CAGR (3Y)
—
Revenue CAGR (5Y)
—
EPS CAGR (3Y)
—
EPS CAGR (5Y)
—
FCF CAGR (3Y)
—
FCF CAGR (5Y)
—
Quality
14 metricsReturn on equity
-60.2%
Return on assets
-50.9%
Debt / equity
0.0
Current ratio
13.4
EBITDA (TTM)
—
Free cash flow (TTM)
—
Quick ratio
13.4
Interest coverage
—
Net debt / EBITDA
—
Return on invested capital
—
Trailing 12 months
Net cash
$117.24M
Latest balance sheet
Cash & equivalents
$22.76M
Total assets
$141.40M
Total debt
$0
Cash flow & spend
7 metricsOperating cash flow (TTM)
−$69.34M
Capital expenditures (TTM)
$126,000
R&D (TTM)
$52.80M
SG&A (TTM)
—
Stock compensation (TTM)
$10.98M
R&D / revenue
—
Stock compensation / revenue
—
Ownership (13F)
9 metrics13F filers
71
13F filer change QoQ
-24
Institutional ownership
75.2%
Conviction holders (share of 13F filers)
0.0%
Crowding (high-turnover and private-fund holders)
66.8%
Private-fund adviser ownership
66.1%
Active holders' share change QoQ
-5.7%
Holder tenure
11.1
Price vs estimated holder cost
-64.9%
Ownership (registered funds)
1 metricsIndex-fund ownership
4.3%
Short interest
3 metricsShort interest
5.5%
Latest settlement · 5.3 days to cover
Days to cover
5.3d
Short-squeeze score
55 / 100
Insider activity
2 metricsNet insider buying (90D)
—
Insider-sentiment score
—
Risk flags
1 metricsGoing concern
—